Literature DB >> 29248001

Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity.

Charles A Dinarello1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29248001      PMCID： PMC5750395          DOI： 10.1111/imr.12624

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  28 in total

1.  Drosophila Toll and IL-1 receptor.

Authors:  N J Gay; F J Keith
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

2.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 3.  The role of the interleukin-1 family in trained immunity.

Authors:  Simone J C F M Moorlag; Rutger Jan Röring; Leo A B Joosten; Mihai G Netea
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

4.  Structural insights into the assembly and activation of IL-1β with its receptors.

Authors:  Dongli Wang; Senyan Zhang; Liang Li; Xi Liu; Kunrong Mei; Xinquan Wang
Journal:  Nat Immunol       Date:  2010-08-29       Impact factor: 25.606

Review 5.  Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

Authors:  Alberto Mantovani; Antonio Sica; Paola Allavena; Cecilia Garlanda; Massimo Locati
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

6.  MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study.

Authors:  David S Hong; David Hui; Eduardo Bruera; Filip Janku; Aung Naing; Gerald S Falchook; Sarina Piha-Paul; Jennifer J Wheler; Siqing Fu; Apostolia M Tsimberidou; Michael Stecher; Prasant Mohanty; John Simard; Razelle Kurzrock
Journal:  Lancet Oncol       Date:  2014-04-17       Impact factor: 41.316

7.  Structural insights into the interaction of IL-33 with its receptors.

Authors:  Xi Liu; Michal Hammel; Yanfeng He; John A Tainer; U-Ser Jeng; Linqi Zhang; Shuying Wang; Xinquan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 8.  The intra- and extracellular functions of ASC specks.

Authors:  Bernardo S Franklin; Eicke Latz; Florian Ingo Schmidt
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 9.  Interleukin 1 gene polymorphism and susceptibility to disease.

Authors:  Khaled Khazim; Etti Ester Azulay; Batya Kristal; Idan Cohen
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 10.  Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.

Authors:  Corinne Cayrol; Jean-Philippe Girard
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988
View more
  22 in total

Review 1.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 2.  Can insulin secreting pancreatic β-cells provide novel insights into the metabolic regulation of the DNA damage response?

Authors:  Bryndon J Oleson; John A Corbett
Journal:  Biochem Pharmacol       Date:  2020-03-12       Impact factor: 5.858

3.  IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii.

Authors:  Joseph T Clark; David A Christian; Jodi A Gullicksrud; Joseph A Perry; Jeongho Park; Maxime Jacquet; James C Tarrant; Enrico Radaelli; Jonathan Silver; Christopher A Hunter
Journal:  Elife       Date:  2021-04-30       Impact factor: 8.140

4.  Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection.

Authors:  Jiang-Ping Meng; Peng Luo; Yao Bai; Fang Cui
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

Review 5.  IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense.

Authors:  Vincent Larochette; Charline Miot; Caroline Poli; Elodie Beaumont; Philippe Roingeard; Helmut Fickenscher; Pascale Jeannin; Yves Delneste
Journal:  Front Immunol       Date:  2019-02-12       Impact factor: 7.561

Review 6.  Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells.

Authors:  Xianfeng Yan; Bin Xie; Guihai Wu; Jing Hu; Di Wang; Xiangna Cai; Jilin Li
Journal:  Mediators Inflamm       Date:  2019-01-08       Impact factor: 4.711

Review 7.  P2X7 Interactions and Signaling - Making Head or Tail of It.

Authors:  Robin Kopp; Anna Krautloher; Antonio Ramírez-Fernández; Annette Nicke
Journal:  Front Mol Neurosci       Date:  2019-08-07       Impact factor: 5.639

Review 8.  Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease.

Authors:  Emmanuel Pinteaux; Wesam H Abdulaal; Ilgiz A Mufazalov; Neil E Humphreys; Maj Simonsen-Jackson; Sheila Francis; Werner Müller; Ari Waisman
Journal:  J Mol Med (Berl)       Date:  2020-05-29       Impact factor: 4.599

Review 9.  Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development.

Authors:  Rishika Chaudhary; Robert A H Scott; Graham Wallace; Martin Berry; Ann Logan; Richard J Blanch
Journal:  Transl Vis Sci Technol       Date:  2020-02-21       Impact factor: 3.283

Review 10.  IL-38: A New Player in Inflammatory Autoimmune Disorders.

Authors:  Lihui Xie; Zhaohao Huang; He Li; Xiuxing Liu; Songguo Zheng; Wenru Su
Journal:  Biomolecules       Date:  2019-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.